» Articles » PMID: 27034076

[Caspase-1 Regulates Autoinflammation in Rheumatic Diseases]

Overview
Journal Z Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2016 Apr 2
PMID 27034076
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Caspase-1 is an integral regulator of the innate immune system. Its core functions are the processing and secretion of the proinflammatory cytokines interleukin 1β (IL-1 beta) and IL-18 and the initiation of proinflammatory cell death, which is referred to as pyroptosis. Activation of caspase-1 plays a pivotal role during immune defense mechanisms against infections by the innate immune system. Dysregulated activation of caspase-1 has been recognized to be involved in the pathophysiology of a constantly increasing number of inflammatory diseases. This article gives an overview of the regulation and function of caspase-1 and its involvement in monogenic, polygenic and/or polyetiological rheumatic diseases.

Citing Articles

An improved understanding of pediatric chronic nonbacterial osteomyelitis pathophysiology informs current and future treatment.

Roberts E, Charras A, Hahn G, Hedrich C J Bone Miner Res. 2024; 39(11):1523-1538.

PMID: 39209330 PMC: 11523093. DOI: 10.1093/jbmr/zjae141.


Optimization of Sperm Cryopreservation Formulation in .

Chang L, Lu C, Zhu J, Chen Y, Wang C, Mu C Int J Mol Sci. 2023; 24(5).

PMID: 36901789 PMC: 10001725. DOI: 10.3390/ijms24054358.


Vasculitis in Cystic Fibrosis.

Sposito F, McNamara P, Hedrich C Front Pediatr. 2020; 8:585275.

PMID: 33282799 PMC: 7690646. DOI: 10.3389/fped.2020.585275.


Role of Smad3 inhibitor and the pyroptosis pathway in spinal cord injury.

Zhu J, Fu Y, Tu G Exp Ther Med. 2020; 20(2):1675-1681.

PMID: 32742397 PMC: 7388327. DOI: 10.3892/etm.2020.8832.


Expression of Caspase-1 in breast cancer tissues and its effects on cell proliferation, apoptosis and invasion.

Sun Y, Guo Y Oncol Lett. 2018; 15(5):6431-6435.

PMID: 29725399 PMC: 5920210. DOI: 10.3892/ol.2018.8176.


References
1.
Fife M, Gutierrez A, Ogilvie E, Stock C, Samuel J, Thomson W . Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther. 2006; 8(5):R148. PMC: 1779449. DOI: 10.1186/ar2041. View

2.
Cavalli G, Dinarello C . Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). 2015; 54(12):2134-44. PMC: 5009422. DOI: 10.1093/rheumatology/kev269. View

3.
Canna S, de Jesus A, Gouni S, Brooks S, Marrero B, Liu Y . An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014; 46(10):1140-6. PMC: 4177369. DOI: 10.1038/ng.3089. View

4.
Beukelman T, Guevara J, Albert D . Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis. Arthritis Rheum. 2008; 59(11):1580-8. DOI: 10.1002/art.24190. View

5.
Bruck N, Schnabel A, Hedrich C . Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Clin Immunol. 2015; 159(1):72-83. DOI: 10.1016/j.clim.2015.04.018. View